按临床验前概率调整d-二聚体阈值诊断肺栓塞
这项前瞻性研究纳入2017例门诊患者,按临床验前概率(C-PTP)调整d-二聚体阈值:低C-PTP且d-二聚体<1000 ng/mL、或中等C-PTP且d-二聚体<500 ng/mL者视为排除肺栓塞、不做进一步影像学检查;其余患者接受胸部影像学检查(通常为CT肺动脉造影),未诊断肺栓塞者不接受抗凝治疗,所有患者随访3个月。1325例低C-PTP(1285例)或中等C-PTP(40例)且d-二聚体阴性者中,随访期间无静脉血栓栓塞症(95%CI 0.00–0.29%),其中包括315例低C-PTP且d-二聚体500–999 ng/mL者(95%CI 0.00–1.20%)。该策略使34.3%的患者接受胸部影像学检查,而低C-PTP且d-二聚体<500 ng/mL即排除肺栓塞的策略为51.9%(差值-17.6个百分点,95%CI -19.2至-15.9)。
要点
- 低C-PTP且d-二聚体<1000 ng/mL、或中等C-PTP且d-二聚体<500 ng/mL的门诊患者可视为排除肺栓塞,1325例中随访3个月无静脉血栓栓塞症(95%CI 0.00–0.29%)。
- 低C-PTP且d-二聚体500–999 ng/mL的315例患者随访3个月无静脉血栓栓塞症(95%CI 0.00–1.20%)。
- 该策略胸部影像学使用率34.3%,低于低C-PTP且d-二聚体<500 ng/mL策略的51.9%(差值-17.6个百分点,95%CI -19.2至-15.9)。
- 1863例初始未诊断肺栓塞且未抗凝的患者中,1例(0.05%;95%CI 0.01–0.30)随访期间发生静脉血栓栓塞症。
- 2017例入组患者中7.4%在初始诊断检查时诊断肺栓塞。
适用人群与场景
- 门诊患者,纳入时按临床验前概率(C-PTP)分层为低或中等。
- 低C-PTP且d-二聚体<1000 ng/mL或中等C-PTP且d-二聚体<500 ng/mL者视为排除肺栓塞、不做进一步影像学检查;其余患者接受胸部影像学检查(通常为CT肺动脉造影)。
- 未诊断肺栓塞者不接受抗凝治疗,所有患者随访3个月检测静脉血栓栓塞症。
诊断标准与关键阈值
- 低临床验前概率(C-PTP)且d-二聚体<1000 ng/mL。
- 中等临床验前概率(C-PTP)且d-二聚体<500 ng/mL。
处置流程与药物剂量
- 低C-PTP且d-二聚体<1000 ng/mL者视为排除肺栓塞,不做进一步影像学检查、不给抗凝治疗。
- 中等C-PTP且d-二聚体<500 ng/mL者视为排除肺栓塞,不做进一步影像学检查、不给抗凝治疗。
- 其余患者接受胸部影像学检查(通常为CT肺动脉造影);未诊断肺栓塞者不接受抗凝治疗。
- 所有患者随访3个月检测静脉血栓栓塞症。
研究设计与关键结果
- 前瞻性研究,纳入2017例门诊患者,7.4%在初始诊断检查时诊断肺栓塞。
- 1325例低C-PTP(1285例)或中等C-PTP(40例)且d-二聚体阴性(分别<1000或<500 ng/mL)者,随访期间无静脉血栓栓塞症(95%CI 0.00–0.29%)。
- 其中315例低C-PTP且d-二聚体500–999 ng/mL者随访期间无静脉血栓栓塞症(95%CI 0.00–1.20%)。
- 1863例初始未诊断肺栓塞且未抗凝的患者中,1例(0.05%;95%CI 0.01–0.30)发生静脉血栓栓塞症。
- 该策略胸部影像学使用率34.3%,低C-PTP且d-二聚体<500 ng/mL策略为51.9%(差值-17.6个百分点;95%CI -19.2至-15.9)。
证据类型、等级与局限
- 证据类型:前瞻性研究(PEGeD,ClinicalTrials.gov NCT02483442)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对门诊低C-PTP患者,d-二聚体<1000 ng/mL即可考虑排除肺栓塞而不行胸部影像学检查;中等C-PTP患者仍以d-二聚体<500 ng/mL为排除阈值。
- 采用该策略可使胸部影像学检查率由51.9%降至34.3%(差值-17.6个百分点,95%CI -19.2至-15.9)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Retrospective analyses suggest that pulmonary embolism is ruled out by a d-dimer level of less than 1000 ng per milliliter in patients with a low clinical pretest probability (C-PTP) and by a d-dimer level of less than 500 ng per milliliter in patients with a moderate C-PTP.
METHODS: We performed a prospective study in which pulmonary embolism was considered to be ruled out without further testing in outpatients with a low C-PTP and a d-dimer level of less than 1000 ng per milliliter or with a moderate C-PTP and a d-dimer level of less than 500 ng per milliliter. All other patients underwent chest imaging (usually computed tomographic pulmonary angiography). If pulmonary embolism was not diagnosed, patients did not receive anticoagulant therapy. All patients were followed for 3 months to detect venous thromboembolism.
RESULTS: A total of 2017 patients were enrolled and evaluated, of whom 7.4% had pulmonary embolism on initial diagnostic testing. Of the 1325 patients who had a low C-PTP (1285 patients) or moderate C-PTP (40 patients) and a negative d-dimer test (i.e., <1000 or <500 ng per milliliter, respectively), none had venous thromboembolism during follow-up (95% confidence interval [CI], 0.00 to 0.29%). These included 315 patients who had a low C-PTP and a d-dimer level of 500 to 999 ng per milliliter (95% CI, 0.00 to 1.20%). Of all 1863 patients who did not receive a diagnosis of pulmonary embolism initially and did not receive anticoagulant therapy, 1 patient (0.05%; 95% CI, 0.01 to 0.30) had venous thromboembolism. Our diagnostic strategy resulted in the use of chest imaging in 34.3% of patients, whereas a strategy in which pulmonary embolism is considered to be ruled out with a low C-PTP and a d-dimer level of less than 500 ng per milliliter would result in the use of chest imaging in 51.9% (difference, -17.6 percentage points; 95% CI, -19.2 to -15.9).
CONCLUSIONS: A combination of a low C-PTP and a d-dimer level of less than 1000 ng per milliliter identified a group of patients at low risk for pulmonary embolism during follow-up. (Funded by the Canadian Institutes of Health Research and others; PEGeD ClinicalTrials.gov number, NCT02483442.).
参考来源
- Kearon C, de Wit K, Parpia S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. N Engl J Med. 2019. PMID: 31774957. doi:10.1056/NEJMoa1909159
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。